In other countries
The same active substances on other registers, the same brand first.
- DexilantCanada · 30 MG · Capsule (Delayed-Release) · Takeda Canada INCSame brand
- DexilantCanada · 60 MG · Capsule (Delayed-Release) · Takeda Canada INCSame brand
- Dexilant®Serbia · 60mg · kapsula sa modifikovanim oslobađanjem, tvrda · Takeda DOOSame brand
- Dexilant®Serbia · 30mg · kapsula sa modifikovanim oslobađanjem, tvrda · Takeda DOOSame brand
- DEXILANT 30 mgSaudi Arabia · Takeda GMBHSame brand
- DEXILANT 30 mgSaudi Arabia · TakedaSame brand
- DEXILANT 60 mgSaudi Arabia · TakedaSame brand
- DEXILANT DELAYED RELEASE CAPSULE 30mgSingapore · 30mg · capsule, delayed release · Takeda Pharmaceuticals (Asia Pacific) Pte. LTD.Same brand
- DEXILANT DELAYED RELEASE CAPSULE 60mgSingapore · 60mg · capsule, delayed release · Takeda Pharmaceuticals (Asia Pacific) Pte. LTD.Same brand
- DexilantUnited States · 30MG, 60MG · capsule, delayed release · Takeda Pharms USASame brand
- Dexilant SolutabUnited States · 30MG · tablet, orally disintegrating, delayed release · Takeda Pharms USASame brand
- Apo-DexlansoprazoleCanada · 30 MG · Capsule (Delayed-Release) · Apotex INCSame substance
- DexlansoprazoleUnited States · 30MG, 60MG · capsule, delayed release · MylanSame substance
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Dexlansoprazole
- Register
- Brazil (Anvisa)
- Status
- Authorised
- Status in the register
- Ativo
- Authorised
- 30 Jan 2012
- Registration
- 106390261
- Marketing authorisation holder
- Takeda Pharma Ltda.
- Procedure
- Registered